StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a research report sent to investors on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The company has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.